Literature DB >> 11571938

Diagnosis and differential diagnosis of Cushing's syndrome.

J W Findling1, H Raff.   

Abstract

The clinical recognition of Cushing's syndrome and its biochemical confirmation is a challenging problem. The best diagnostic approach to patients with suspected Cushing's syndrome is still evolving. The traditional diagnostic approach of urine free cortisol and low-dose dexamethasone suppression testing may be inadequate when the degree of hypercortisolism is mild. Late-night salivary cortisol determinations may evolve as the simplest means of screening patients for suspected hypercortisolism. Repeated measurements of cortisol secretion (urine free cortisol or late-night salivary cortisol) over an extended period of time may be necessary to provide diagnostic certainty. The dexamethasone-CRH test is a reasonable approach in patients with equivocal data. The introduction of reliable, sensitive, and specific plasma ACTH measurements, the use of IPSS for ACTH with CRH stimulation, and the improved techniques of pituitary and adrenal imaging have made the differential diagnosis of Cushing's syndrome relatively straightforward (see Fig. 2). Clinicians who have never missed the diagnosis of Cushing's syndrome or have never been fooled by attempting to establish its cause should refer their patients with suspected hypercortisolism to someone who has.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571938     DOI: 10.1016/s0889-8529(05)70209-7

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  21 in total

1.  Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.

Authors:  C A Carrasco; M García; M Goycoolea; J Cerda; J Bertherat; O Padilla; D Meza; N Wohllk; T Quiroga
Journal:  Endocrine       Date:  2012-01-24       Impact factor: 3.633

Review 2.  Cushing's syndrome: diagnosis and surveillance using salivary cortisol.

Authors:  Hershel Raff
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

3.  Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing's disease.

Authors:  Jung Soo Lim; Seung Ku Lee; Se Hoon Kim; Eun Jig Lee; Sun Ho Kim
Journal:  Endocrine       Date:  2011-06-19       Impact factor: 3.633

Review 4.  The inferior petrosal sinus: a comprehensive review with emphasis on clinical implications.

Authors:  Martin M Mortazavi; Christoph J Griessenauer; Sanjay Krishnamurthy; Ketan Verma; Marios Loukas; R Shane Tubbs
Journal:  Childs Nerv Syst       Date:  2014-02-14       Impact factor: 1.475

Review 5.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

6.  High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.

Authors:  T C Friedman; D E Ghods; H K Shahinian; L Zachery; N Shayesteh; S Seasholtz; E Zuckerbraun; M L Lee; I E McCutcheon
Journal:  Horm Metab Res       Date:  2010-08-27       Impact factor: 2.936

Review 7.  Pituitary tumor diagnosis and treatment.

Authors:  Paul L Penar; David J Nathan; Muriel H Nathan; Afshin Salsali
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 8.  Is metabolic syndrome a mild form of Cushing's syndrome?

Authors:  Armand Krikorian; Mehreen Khan
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

Review 9.  Novel pituitary ligands: peroxisome proliferator activating receptor-gamma.

Authors:  Anthony P Heaney
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

10.  Diagnostic efficacy of midnight cortisol and midnight ACTH in the diagnosis and localisation of Cushing's syndrome.

Authors:  Mathew John; Anurag R Lila; Tushar Bandgar; Padma S Menon; Nalini S Shah
Journal:  Pituitary       Date:  2010       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.